Physician profile
John Wallington
NPI 1265819577
$1,309.32
in general payments reported to CMS, 2019-2025
14 companies · $705 in 2025
The $705 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2021: $30.85 · 2022: $58.50 · 2023: $149 · 2024: $140 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $289.05 | 2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $238.53 | 2025 | Unid_pass, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Alphatec Spine, INC | $197.14 | 2024-2025 | Other - Miscellaneous |
| Spr Therapeutics, INC | $125.33 | 2022-2025 | Sprint Pns System |
| Radius Health, INC. | $119.76 | 2019 | |
| Genzyme Corporation | $106.87 | 2019 | |
| Abbvie INC. | $98.27 | 2023 | Botox |
| Bioventus LLC | $33.67 | 2021-2023 | Durolane |
| Heron Therapeutics, INC. | $21.92 | 2023 | Zynrelef |
| Ossur Americas, INC. | $21.58 | 2025 | |
| Fidia Pharma USA INC. | $17.83 | 2025 | Hymovis, Triluron |
| Depuy Synthes Sales INC. | $13.71 | 2023 | Monovisc, Orthovisc |
| Djo, LLC | $13.66 | 2024 | Cmf |
| Biohaven Pharmaceuticals, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wallington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.